An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.
This study has been completed.
Sponsor:
Tibotec Pharmaceuticals, Ireland
Information provided by:
Tibotec Pharmaceuticals, Ireland
ClinicalTrials.gov Identifier:
NCT00081588
First received: April 15, 2004
Last updated: June 2, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2008 |
| Primary Completion Date: | September 2005 (Final data collection date for primary outcome measure) |